Exploring AMERISAFE, Inc. (AMSF) Investor Profile: Who’s Buying and Why?

Exploring AMERISAFE, Inc. (AMSF) Investor Profile: Who’s Buying and Why?

US | Financial Services | Insurance - Specialty | NASDAQ

AMERISAFE, Inc. (AMSF) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

You're looking at AMERISAFE, Inc. (AMSF) and wondering why the stock is moving, because frankly, the third quarter 2025 net income of $13.8 million, a 3.5% dip year-over-year, doesn't tell the whole story. The real driver is the investor profile, which is overwhelmingly institutional-hedge funds and other large entities own a striking 97.41% of the stock. Think about that concentration. When firms like BlackRock, Inc. and The Vanguard Group, Inc. hold millions of shares, their conviction about this niche workers' compensation insurer, focused on high-hazard industries, matters. For instance, BlackRock, Inc. alone holds over 3.3 million shares, making them a top holder. They're not buying for a quick flip; they're buying for the capital management story, specifically the return of capital, like the recent declaration of a special cash dividend of $1.00 per share alongside the regular $0.39 quarterly dividend. Plus, the company's book value per share is up 7.1% year-to-date to $14.47 as of September 30, 2025. So, are these institutional giants seeing a stable, cash-generating niche business, or is there a defintely near-term risk in that premium growth? Let's break down who is buying, who is selling, and what that tells us about the stock's future trajectory.

Who Invests in AMERISAFE, Inc. (AMSF) and Why?

The investor profile for AMERISAFE, Inc. (AMSF) is straightforward: it is overwhelmingly dominated by large institutions, with their primary motivation being the company's exceptional capital return, particularly its high dividend yield and special payouts. This isn't a high-growth, tech-style stock; it's a value and income play, plain and simple.

As of late 2025, institutional investors-the mutual funds, pension funds, and asset managers-own a staggering 97.41% of the company's common stock. That high concentration means the stock's movement is heavily influenced by the quarterly decisions of major players like Vanguard Group Inc. and BlackRock, Inc., who are among the top holders. Retail investors, while present, represent a small fraction of the total ownership. Insider ownership, held by executives and directors, is low at just 3.44%, which is something to keep an eye on.

Key Investor Types and Their Footprint

The ownership structure clearly maps to three distinct investor groups, each with a different risk tolerance and time horizon. Here's a quick math breakdown of who holds the reins:

  • Institutional Investors: Own nearly all the stock, primarily through index funds and large-cap value funds. Their sheer size means their trades move the market.
  • Retail Investors: Individual accounts are drawn to the stock's stability and consistent dividend history, looking for a reliable income stream in their retirement portfolios.
  • Hedge Funds: A smaller, but more active, group of hedge funds and other institutional investors may engage in short-term trading, often looking to capitalize on price movements around earnings or special dividend announcements.

You can see the scale of the institutional commitment by looking at the top holders. Firms like BlackRock Fund Advisors and The Vanguard Group, Inc. hold millions of shares, representing a significant portion of the entire float.

The Real Investment Motivations: Income and Value

Investors are attracted to AMERISAFE, Inc. (AMSF) not for explosive revenue growth, but for its conservative underwriting, strong capital position, and commitment to returning capital to shareholders. The company's focus on high-hazard workers' compensation insurance provides a niche stability that appeals to financial professionals.

The most compelling motivation is the dividend. The annual dividend is approximately $2.56 per share, giving a current yield of around 6.16% as of November 2025. Plus, the company has a history of paying substantial special dividends, such as the $1.00 special dividend announced for December 2025. This commitment to capital return pushes the shareholder yield to an impressive 6.46%.

Another major draw is the discounted valuation. The stock trades around $40.91 (as of November 2025), which is well below the estimated fair value of $55.41. This discount, coupled with a healthy Return on Equity (ROE) of 20.2% in 2024, signals a classic value opportunity for those who believe the market is overly pessimistic. The net profit margin of 16.5% as of October 2025 also shows the profitability of their specialized model.

Strategies in Play: Long-Term Income vs. Short-Term Risk

The dominant strategy among the institutional base is Long-Term Holding and Income Investing. Firms like Vanguard and BlackRock often hold the stock for years in their index and dividend-focused funds, prioritizing the consistent quarterly payout of $0.39 per share.

However, you also see Value Investing at play, driven by the valuation gap. Value investors are buying now, believing the stock will revert to its intrinsic value closer to the analyst consensus price target, which averages around $55.00 to $58.25 for the next twelve months. That represents a potential upside of over 30% from the current price.

What this estimate hides is the near-term risk. Revenue growth is projected at only 4.8% annually, which is half the broader US market's pace. This slow growth, plus rising operating costs (the expense ratio hit 31.3% in Q3 2025, up from 29.8% a year prior), means investors must be defintely patient. For a deeper dive into the company's foundation, check out AMERISAFE, Inc. (AMSF): History, Ownership, Mission, How It Works & Makes Money.

Here is a snapshot of the key financial metrics driving investor interest in 2025:

Metric 2025 Value (Approx.) Investor Motivation
Institutional Ownership 97.41% Stability, Index Inclusion
Annual Dividend Per Share $2.56 Income Generation
Forward Dividend Yield 9.69% High Capital Return
Estimated Fair Value $55.41 Value Investing Opportunity
Q2 2025 Book Value Per Share $13.96 Balance Sheet Strength

The bottom line is you're investing in a mature, cash-generating business that uses its profits to reward shareholders, not one that is plowing all its money back into aggressive expansion.

Institutional Ownership and Major Shareholders of AMERISAFE, Inc. (AMSF)

If you're looking at AMERISAFE, Inc. (AMSF), the first thing to understand is that it's an institutionally-dominated stock. This isn't a retail-driven story; it's a play for large funds. Institutional investors-the mutual funds, pension funds, and asset managers-own a staggering 97.41% of the company's stock. That level of ownership means the big players essentially control the float, and their decisions drive the stock's price movements and, often, the company's strategic focus.

Top Institutional Investors and Their Stakes

As of the end of the second quarter of 2025 (June 30, 2025), the list of top shareholders in AMERISAFE, Inc. reads like a who's who of the asset management world. These institutions hold massive positions, signaling their long-term conviction in the specialty workers' compensation insurer, which focuses on high-hazard industries like construction and logging. They are buying into the company's niche focus and consistent underwriting performance.

Here's a quick look at the largest holders from the Q2 2025 filings:

Major Institutional Investor Shares Held (as of 6/30/2025) Quarterly Change in Shares
Blackrock, Inc. 3,312,495 -104,843
Neuberger Berman Group Llc. 1,738,167 -48,621
Vanguard Group Inc. 1,420,034 -23,551
Morgan Stanley 876,424 +61,699
Champlain Investment Partners, Llc. 797,663 -51,324

Blackrock, Inc. and Vanguard Group Inc. are your anchor investors here. They are passive giants, meaning they hold the stock primarily because AMERISAFE, Inc. is part of major market indices, not necessarily due to a specific trading strategy. Still, their combined holdings represent a huge, relatively stable base of capital.

Recent Shifts in Institutional Ownership

The institutional ownership picture isn't static; it's a constant churn of buys and sells, and the most recent data from the 2025 fiscal year shows a mixed, but slightly cautious, trend among the largest holders. While the overall institutional stake remains high, many of the top five firms slightly reduced their positions in Q2 2025.

  • Selling: Blackrock, Inc. pared back its stake by 3.068%, selling 104,843 shares. Neuberger Berman Group Llc. also reduced its position by 2.721%. This is a minor trimming, not a panic exit, but it's defintely something to watch.
  • Buying: Not everyone was selling. Morgan Stanley, for example, increased its holdings significantly, adding 61,699 shares. More dramatically, smaller funds like Campbell & CO Investment Adviser LLC grew their stake by a massive 243.7% in Q2 2025, purchasing an additional 11,546 shares.

This tells you that while the mega-funds are rebalancing-maybe taking some profits-other institutions are seeing a buying opportunity. The smaller, more active funds are aggressively building positions, believing the stock is undervalued or that its Mission Statement, Vision, & Core Values of AMERISAFE, Inc. (AMSF) will drive future performance.

The Role of Large Investors in Strategy and Price

With nearly all shares held by institutions, these investors play a critical role in AMERISAFE, Inc.'s stock price and corporate strategy. Their concentration of ownership means that a coordinated move by even a few large funds can significantly impact the share price.

Here's the quick math: if a fund holding 1 million shares decides to sell, that's a huge supply shock for a stock with only about 18.9 million shares outstanding.

The influence also extends to capital allocation. The company's recent actions, like the announcement of a special dividend of $1.00 per share payable in December 2025, are a clear nod to its institutional investor base, many of whom prioritize return of capital. This special dividend, which analysts note represents an unusually high yield, is a direct way to reward shareholders, especially in a year where Q3 2025 revenue of $71.29 million missed analyst expectations of $78.29 million. The institutional focus is on the company's strong core underwriting performance and capital efficiency, even if top-line revenue growth is volatile.

Next step: Dig into the latest analyst reports to see if the recent institutional selling is tied to any specific concerns about the company's reserve adequacy or investment portfolio.

Key Investors and Their Impact on AMERISAFE, Inc. (AMSF)

You want to know who is really buying AMERISAFE, Inc. (AMSF) and what their moves mean for your investment. The direct takeaway is that AMERISAFE is overwhelmingly an institutional play, with these large funds owning nearly all the stock, which generally points to stability but also means their collective moves drive the price.

As of the 2025 fiscal year, institutional investors-think mutual funds, pension funds, and major asset managers-own a staggering 97.41% of AMERISAFE's outstanding shares. This high concentration means the company is largely held by long-term, passive investors who are drawn to its niche focus on high-hazard workers' compensation insurance and its consistent dividend policy. It's a classic low-volatility, income-oriented stock for them. That's a defintely high number.

The top holders are the names you'd expect to see in a stable, dividend-paying company. The largest stakes are held by financial giants who manage trillions in assets, making them the most notable investors in AMERISAFE, Inc. (AMSF).

  • BlackRock, Inc.: A top holder with around 3,312,495 shares as of mid-2025.
  • The Vanguard Group, Inc.: Another passive investing behemoth, holding approximately 1,372,829 shares in late 2025.
  • Neuberger Berman Group LLC: A significant active manager, holding roughly 1,738,167 shares.

Investor Influence: Stability Over Activism

The influence of these major investors on AMERISAFE, Inc. (AMSF) is less about activist demands and more about corporate governance and capital allocation. Because the top holders-like BlackRock and Vanguard-are largely passive index or quantitative funds, their primary influence is on long-term strategy, board composition, and the dividend payout ratio. They aren't typically pushing for a sale or a massive operational overhaul.

Their presence validates the company's business model. When institutions hold a total value of holdings around $734 million in the stock, it signals confidence in the management's ability to maintain a strong book value per share, which was $14.47 as of September 30, 2025. The institutional base essentially acts as a floor for the stock, providing stability, but it also means there's less room for a short-term activist-driven pop.

Recent Moves and the Dividend Signal

Recent investor activity, based on Q3 2025 13F filings, shows a mixed picture, which is normal for a mature, dividend-focused stock. The key takeaway here is that while some funds are trimming positions for rebalancing, others are stepping in, attracted by the consistent cash flow and special dividends. The recent moves often revolve around the company's generous capital return policy.

For example, in Q2 2025, BlackRock, Inc. reduced its stake by 3.068%, selling 104,843 shares as part of a portfolio rebalancing. Similarly, The Vanguard Group, Inc. trimmed its position by 3.3% in early November 2025. But to be fair, you also see funds increasing their exposure, like Granite Investment Partners LLC, which boosted its stake by 19.5% in November 2025. This is just portfolio managers doing their job.

The biggest recent signal that attracts and retains this investor base is the company's dividend. AMERISAFE, Inc. (AMSF) declared a special cash dividend of $1.00 per share and a regular cash dividend of $0.39 per share in the third quarter of 2025. This kind of capital return is exactly what keeps income-focused institutional investors interested, even with Q3 2025 revenue coming in at $71.29 million, which was slightly below expectations. You can learn more about the underlying philosophy driving this stability here: Mission Statement, Vision, & Core Values of AMERISAFE, Inc. (AMSF).

Here is a snapshot of some major institutional moves in the 2025 fiscal year:

Institutional Investor Reporting Date (2025) Shares Held (Approx.) Quarterly Change (%)
BlackRock, Inc. June 30 3,312,495 -3.068%
The Vanguard Group, Inc. November 7 1,372,829 -3.3%
Charles Schwab Investment Management Inc. Q1 723,562 +9.3%
Dimensional Fund Advisors LP June 30 520,152 -6.541%
Granite Investment Partners LLC November 10 115,743 +19.5%

The action item is to watch the overall institutional ownership percentage and the dividend policy. If that 97.41% ownership level drops significantly, or if the special dividend is cut, then you have a real reason to reassess the investment thesis. Until then, the big money is happy to collect the income.

Market Impact and Investor Sentiment

You're looking for a clear read on AMERISAFE, Inc. (AMSF) investor sentiment, and the signal is a cautious but defintely positive 'Moderate Buy' from the analyst community, despite some near-term headwinds. This consensus rating is a practical reflection of the company's solid capital management against a backdrop of soft industry pricing.

The market is clearly rewarding AMERISAFE, Inc.'s commitment to shareholder returns. The announcement of a $1.00 per share special cash dividend on October 29, 2025, was a strong vote of confidence from management, immediately following their Q3 2025 earnings beat. This special dividend, combined with the regular quarterly dividend of $0.39 per share, underscores a disciplined capital strategy that appeals directly to income-focused investors.

The stock is currently trading at a significant discount, which is a key driver for value investors. Here's the quick math: the stock price of around $41.40 is a notable 27.8% discount to the estimated Discounted Cash Flow (DCF) fair value of $55.41. This valuation disconnect suggests the market is skeptical about the durability of future profits, but for a seasoned investor, that gap is the opportunity.

The Anchor of Major Institutional Shareholders

The investor profile for AMERISAFE, Inc. is overwhelmingly institutional, with hedge funds and other large entities owning a massive 97.41% of the company's stock. This means the stock's stability and trading volume are heavily influenced by the buy/sell decisions of a few giants.

The presence of behemoths like BlackRock, Inc. and The Vanguard Group, Inc. acts as a crucial anchor. BlackRock, Inc. is the top holder, with 3,315,136 shares as of the end of Q3 2025, showing a virtually flat holding change from the previous quarter. The Vanguard Group, Inc. is also a major player, holding 1,372,829 shares, though they did trim their position by -3% in Q3 2025-likely a minor reallocation, not a flight.

But not all institutional moves were flat or down. Value-oriented managers were buying. For instance, Royce & Associates LP significantly increased its position, adding 97,434 shares for a 21% quarterly change, bringing their total to 555,621 shares. This kind of aggressive accumulation by a dedicated small-cap manager signals a strong belief in the long-term value story.

  • BlackRock, Inc. holds 3.31 million shares-a stable anchor.
  • Royce & Associates LP boosted its stake by 21% in Q3 2025.
  • Institutional ownership sits at nearly 97.41% overall.

Recent Market Reactions and Analyst Perspectives

The stock market's reaction to the Q3 2025 earnings, reported on October 29, 2025, was a clear positive. AMERISAFE, Inc. reported earnings per share (EPS) of $0.72, which was a 28.57% surprise over the forecasted $0.56. Revenue also came in strong at $80.32 million, beating the expected $78.69 million. The stock responded with a modest 1.28% increase post-announcement, closing at $39.73.

Still, the analyst landscape is mixed, which is why the consensus is only a 'Moderate Buy.' While Citigroup reiterated a 'Market Outperform' rating on October 30, 2025, JMP Securities cut their price target from $65.00 to $60.00 on October 14, 2025, though they kept their 'Market Outperform' rating. Truist Financial also lowered their target to $50.00 in July 2025 and maintained a 'Hold.' This shows a slight pull-back on the most bullish expectations.

The average 12-month price target from analysts is currently around $55.00, suggesting an upside potential of about 32.9% from the recent trading price of $41.40. This target hinges on the company's ability to maintain its underwriting discipline and manage rising expenses, especially the expense ratio which climbed to 31.3% in Q3 2025, up from 29.8% a year prior.

Here is a snapshot of the key analyst perspectives as of late 2025:

Analyst Firm Latest Action Date Rating Price Target
Citigroup 10/30/2025 Reiterated Market Outperform N/A (Positive Implied)
JMP Securities 10/14/2025 Maintained Market Outperform $60.00 (Down from $65.00)
Truist Financial 07/28/2025 Maintained Hold $50.00 (Down from $54.00)

The key takeaway is that the market is waiting for a clear signal that revenue growth will accelerate faster than the expense ratio. The strong underwriting results, reflected in the company's Mission Statement, Vision, & Core Values of AMERISAFE, Inc. (AMSF)., are what keep the institutional money anchored, but top-line growth needs to follow. Your next step should be to model how a 4.8% projected annual revenue growth rate will impact margins over the next three years, compared to the broader US market's 10.3% pace.

DCF model

AMERISAFE, Inc. (AMSF) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.